The global platelet function test market is projected to be valued at USD 1.38 billion in 2025 and is expected to reach USD 2.61 billion by 2035, registering a CAGR of 6.3% during the forecast period.

Randomized trials of platelet function and genetic testing to guide antiplatelet decisions following PCI have produced notoriously mixed results: now, an updated consensus document aims to fill some ...

The global platelet function test market is poised for robust growth over the next decade, fueled by innovations in diagnostic technologies and increasing demand for personalized, preventive ...

Aspirin is widely prescribed for the secondary prevention of ischemic stroke and acute coronary syndromes, but some patients do not respond to this therapy. There is evidence that these ...

Despite no slam-dunk evidence supporting the use of guided dual antiplatelet therapy (DAPT) strategies, either with platelet function or genotype testing, a new review paper argues that there’s still ...

November 15, 2009 (Orlando, Florida) — Results for the first head-to-head comparison of different platelet-function tests suggests that a handful of platelet reactivity assays--used to test the ...

An experimental genetic test can gauge a person's risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than double the rate of heart ...

Medically reviewed by Doru Paul, MD Key Takeaways An MPV blood test measures the average size of your platelets, which can suggest certain health conditions.High MPV, with larger cells, means your ...

(Ivanhoe Newswire) -- An analysis of six tests used to measure platelet function and gauge the effectiveness of anti-platelet drugs for patients undergoing a cardiac procedure such as a coronary stent ...

Ado-trastuzumab emtansine (T-DM1) treatment results in grade 3-4 thrombocytopenia in 8%-13% of patients. Prior in vitro studies reported T-DM1 inhibition of megakaryocyte maturation as the cause of ...